ILAE-North America
News
World News
Survey on epilepsy stereo-electroencephalography (SEEG) surgery terminology
The purpose of this survey is to assess the various opinions regarding the SEEG terminology and surgery outcome scores from the clinical community across the globe, and establish a reasonable consensus.
7 March, 2023
Clinical Research
Randomized placebo-controlled crossover trial of memantine in children with epileptic encephalopathy
Memantine is an N-methyl-D-aspartate receptor antagonist, approved for dementia treatment. There is limited evidence of memantine showing benefit for paediatric neurodevelopmental phenotypes, but no randomized placebo-controlled trials in children with developmental and epileptic encephalopathy.
6 March, 2023
About ILAE
ILAE-IBE Joint Statement on International Epilepsy Day 2023
Today, on International Epilepsy Day, the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) are calling for greater understanding and intersectoral action to tackle the stigma and discrimination faced by people with epilepsy worldwide.
13 February, 2023
About ILAE
In Memoriam: James J. Cereghino
James J. Cereghino, MD, 85, died on 1 December 2022, in Portland, Oregon, USA, of cardiac failure. Dr. Cereghino will be missed by his national and international colleagues, his friends, and his patients.
20 January, 2023
World News
Improving the lives of people with epilepsy
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
12 December, 2022
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community